Cinctive Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Cinctive Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-58,000	Closed	-$1.02M	–	701
2021 Q3	$1.02M	Buy	+58,000	New	+$678K	0.05%	395

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Cinctive Capital Management's TRIL Position: Q4 2021 in Review

Cinctive Capital Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 58,000 shares — an estimated $1.02M sold.

Cinctive Capital Management first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $1.02M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Cinctive Capital Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Cinctive Capital Management sold 58,000 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $1.02M.
Cinctive Capital Management first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Cinctive Capital Management's Trillium Therapeutics Inc. position peaked at $1.02M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Cinctive Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.